Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination therapy** of the pharmaceutical drug ibuprofen and the medical device ThermaCare heat wraps, used together for the relief of musculoskeletal pain, particularly for conditions such as acute neck pain and low back pain[1][3]. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain, inflammation, and fever by inhibiting cyclooxygenase (COX) enzymes, thus decreasing prostaglandin synthesis. ThermaCare heat wraps deliver continuous low-level heat (~40°C for hours), increasing blood flow locally, relaxing muscles, and accelerating tissue healing[4]. The combination aims to enhance pain control and functional improvement beyond either therapy alone by combining systemic anti-inflammatory action with local thermotherapy[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ibuprofen + ThermaCare heat wraps.